Skip to main content
. 2015 Sep 7;6(32):33191–33205. doi: 10.18632/oncotarget.5052

Table 1. Low CVR is Associated with Immune Enrichment and Higher Prognostic Power.

CVRlow CVRhigh CVRrandom
Immune annotation Non immune annotation Total Immune annotation Non immune annotation Total Immune annotation Non immune annotation Total
Entire gene set 257 243 500 29 471 500 52 448 500
Survival* immFocus 41 25 66 0 0 0 5 13 18
Survival* raw 16 23 39 5 27 32 10 82 92

The counts represent the number of genes from each CVR group that met the mentioned criteria.

*

The counts represent the number of genes whose expression was significantly associated with survival (log-rank test) following multiple testing adjustments (Bonferroni adjustment).